Kayne Anderson Energy Infrastructure Fund Announces Increase in Monthly Distribution
Globenewswire· 2025-12-18 21:15
HOUSTON, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) has declared a monthly distribution of $0.085 per share for January 2026. This represents a 6.3% increase over the prior monthly distribution rate (increase of $0.005 per share). The distribution will be paid on January 30, 2026, as outlined in the table below. “We understand how important distributions are to the Company’s investors, and our goal is to steadily increase KYN’s distribution over time as ...
Stifel Reports November 2025 Operating Data
Globenewswire· 2025-12-18 21:15
ST. LOUIS, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for November 30, 2025, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, “Total client assets and fee-based client assets reached record highs in November, up 8% and 14% year-over-year, driven by ...
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Globenewswire· 2025-12-18 21:15
VALENCIA, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that Cary Vance, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 5:15 p.m. Pacific Time. A live audio webcast of the presentation will be accessible under the Events & Presentations section of AVITA Medical's website at https://ir.avit ...
Scripps Sports becomes local TV home for NWSL’s Denver Summit FC
Globenewswire· 2025-12-18 21:15
DENVER and CINCINNATI, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Scripps Sports has secured exclusive local broadcast rights to Denver Summit FC, the National Women’s Soccer League’s newest franchise, launching in 2026. Under the multiyear agreement, The E.W. Scripps Company (NASDAQ: SSP) will air all non-nationally exclusive matches on its local stations Denver7 (KMGH-TV) and The Spot Denver 3 (KCDO-TV). The deal builds on Scripps Sports’ existing NWSL national partnership, where ION broadcasts premier Saturday ev ...
Mission Produce® Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
Globenewswire· 2025-12-18 21:07
Achieved record full year revenue of $1.39 billion, an increase of 13% year-over-year, driven by strong execution in Marketing & Distribution and significantly higher yields from owned Peruvian orchards in International Farming Generated nearly $180 million in cash flow from operations over the past two years; capital expenditures expected to step down to approximately $40 million in FY26 as Company enters phase of accelerated free cash flow generation Announced leadership succession plan in conjunction wit ...
Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference
Globenewswire· 2025-12-18 21:05
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that that Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA on Tuesday, January 13, 2026 at 9:45 a.m. Pacific Time. To access the live audio-only webcast, click here. The archived webcast will also be accessible on the Events & Presentations page in the Investors section of the Cr ...
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
Globenewswire· 2025-12-18 21:05
FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D., Ph.D., to the Company’s Board of Directors. Dr. Bot is a biopharma executive with three decades of experience in research and development (R&D) with a focus on immune, cell, gene therapy and nanomedicines. He will serve as a member of the Science and Technolog ...
NANO Nuclear Reports Fiscal Year 2025 Financial Results and Provides Business Update
Globenewswire· 2025-12-18 21:05
NANO Nuclear Energy Inc. NANO Nuclear Reports Fiscal Year 2025 Financial Results and Provides Business Update Management to hold webcast today at 5:00 pm Eastern New York, N.Y., Dec. 18, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today reported its fiscal year 2025 financial results and provided a business update. Figure 1 - NANO N ...
Mission Produce® Announces Leadership Succession and Provides Update on Board Refreshment Initiative
Globenewswire· 2025-12-18 21:05
Founder & CEO Steve Barnard to Transition to Executive Chairman of the Board; President and COO John Pawlowski to Become CEO at the close of the Annual Meeting of Shareholders in April 2026 Board Refreshment Initiative Underway –Three New Independent Directors Appointed in Advance of Expected Retirement of Current Board Chair at close of the Annual Meeting OXNARD, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”) a world leader in sourcing, producing, ...
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Globenewswire· 2025-12-18 21:05
Core Viewpoint - Medline Inc. has successfully completed its upsized initial public offering (IPO) of 248,439,654 shares of Class A common stock at a price of $29.00 per share, including the underwriters' option to purchase an additional 32,405,172 shares [1] Group 1: IPO Details - The proceeds from the issuance of 179,000,000 shares will be used to repay outstanding indebtedness under senior secured term loan facilities, with the remainder allocated for general corporate purposes and offering expenses [2] - Medline plans to use proceeds from the issuance of 37,034,482 shares and the additional shares purchased by underwriters to buy or redeem an equivalent number of outstanding equity interests from certain pre-IPO owners [2] - The Class A common stock of Medline is listed on the Nasdaq Global Select Market under the symbol "MDLN" [2] Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan acted as global coordinators and lead bookrunning managers for the offering [2] - A wide range of firms, including Barclays, Citigroup, and Deutsche Bank Securities, served as bookrunning managers, while numerous others acted as co-managers for the offering [2] Group 3: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care [5] - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving clinical, financial, and operational outcomes for healthcare providers [5] - Headquartered in Northfield, Illinois, Medline employs over 43,000 people globally and operates in more than 100 countries [5]